Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 5, Number 4, August 2013, pages 309-315


Efficacy of Vitamin C Vaginal Tablets as Prophylaxis for Recurrent Bacterial Vaginosis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Figure

Figure 1.
Figure 1. Proportion of patients free of BV relapse after three-cycle and six-cycle periods of prophylaxis (Intention-to-treat population, n = 142).

Tables

Table 1. Demographic and Baseline Characteristics in the Two Treatment Groups (Intention to Treat Population)
 
VariableVitamin C
(n = 74)
Placebo
(n = 68)
Total
(n = 142)
Demographic data7468142
Age (years) (mean ± SD)31.2 ± 7.731.0 ± 7.231.1 ± 7.4
Body weight (kg) (mean ± SD)61.0 ± 9.460.5 ± 8.460.8 ± 8.9
Height (cm) (mean ± SD)165.3 ± 5.7165.9 ± 6.2165.6 ± 5.9
Itching (mean ± SD)0.15 ± 0.40.16 ± 0.370.15 ± 0.38
Burning (mean ± SD)0.14 ± 0.340.13 ± 0.380.13 ± 0.36
Dysuria (mean ± SD)0.03 ± 0.160.04 ± 0.210.04 ± 0.19
Odour (mean ± SD)0.09 ± 0.30.19 ± 0.430.14 ± 0.37
Erythema (mean ± SD)0.01 ± 0.120.06 ± 0.240.04 ± 0.19
Oedema (mean ± SD)0.00 ± 0.000.03 ± 0.170.01 ± 0.12
Fissures (mean ± SD)0.00 ± 0.000.01 ± 0.120.01 ± 0.08

 

Table 2. Patients With at Least One AE (Safety Population)
 
Adverse eventTreatment group
Vitamin C (n = 74)Placebo (n = 68)
Burning, itching, skin irritation3 (4.0%)4 (5.9%)
Candidiasis1 (1.4%)1 (1.5%)
Cystitis-1 (1.5%)
Nausea-1 (1.5%)
Bronchitis1 (1.4%)-
Major depression-1 (1.5%)
Flu-1 (1.5%)